Skip to main content Accessibility help
×
Home
  • Print publication year: 2018
  • Online publication date: February 2018

Chapter 18B - Management of Obstetric Hemorrhage: Anesthetic Management

from Section 7 - Hemorrhagic Disorders
1.Knight, M, Kenyon, S, Brocklehurst, P et al. (eds) on behalf of MBRRACE. Saving Lives, Improving Mothers’ Care – Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–12. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2014.
2.Healthcare Improvement Scotland. Scottish Confidential Audit Severe Maternal Morbidity 10th Annual Report; 2014. http://www.healthcareimprovementscotland.org/our_work/reproductive,_maternal_child/programme_resources/scasmm.aspx (accessed April 28 2015).
3.Association of Anesthetists of Great Britain and Ireland; Thomas, D, Wee, M, Clyburn, P et al. Blood transfusion and the anesthetist: management of massive hemorrhage. Anaesthesia 2010; 65(11): 11531161.
4.Draycott, T, Winter, C, Crofts, J, Barnfield, S. Practical Obstetric Multi-professional Training (PROMPT) Trainer’s Manual. London: RCOG Press; 2008.
5.Crofts, JF, Ellis, D, Draycott, TJ et al. Change in knowledge of midwives and obstetricians following obstetric emergency training: a randomised controlled trial of local hospital, simulation center and teamwork training. BJOG: An International Journal of Obstetrics and Gynecology 2007; 114: 15341541.
7.National Institute for Health and Care Excellence. Detecting, Managing and Monitoring Hemostasis: Viscoelastometric Pointofcare Testing (ROTEM, TEG and Sonoclot Systems) Diagnostic Guidance 13: DG13; 2014. http://www.nice.org.uk/guidance/dg13 (Accessed July 13 2015).
8.Perel, P, Roberts, I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Systematics Reviews 2007; 17: CD000567.
9.RCOG. Postpartum Hemorrhage, Prevention and Management. Green-Top Guideline No. 52. London: Royal College of Obstetricians and Gynecologists; 2015. https://www.rcog.org.uk/globalassets/documents/guidelines/gt52postpartumhemorrhage0411.pdf (accessed April 28 2015).
10.Lilley, G, Burkett-St-Laurent, D, Precious, E et al. Measurement of blood loss during postpartum hemorrhage. International Journal of Obstetric Anesthesia 2015; 24(1): 814.
11.RCOG. Placenta Previa, Placenta Previa Accreta and Vasa Previa: Diagnosis and Management. Green-Top Guideline No. 27. London: Royal College of Obstetricians and Gynecologists; 2015. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_27.pdf (accessed April 28 2015).
12.Charbit, B, Mandelbrot, L, Samain, E et al. PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 2007; 5(2): 266273.
13.Stainsby, D, MacLennan, S, Thomas, D, Isaac, J, Hamilton, PJ. Guidelines on the management of massive blood loss. British Journal of Haematology 2006; 135: 634641.
14.Allard, S, Green, L, Hunt, BJ. How we manage the hematological aspects of major obstetric hemorrhage. British Journal of Haematology 2014; 164(2): 177188.
15.Wikkelsø, AJ, Edwards, HM, Afshari, A et al. FIB-PPH trial group. Pre-emptive treatment with fibrinogen concentrate for postpartum hemorrhage: randomized controlled trial. British Journal of Anaesthesia 2015; 114(4): 623633.
16.Collins, PW, Cannings-John, R, Bruynseels, D et al.; the OBS2 Study Team. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. British Journal of Anaesthesia 2017; aex181. doi:10.1093/bja/aex181 (accessed July 26 2017).
17.World Health Organization. Recommendations for the Prevention and Treatment of Postpartum Hemorrhage. Geneva: WHO; 2012. http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548502/en/ (accessed April 28 2015).
18.Ducloy-Bouthors, AS, Jude, B, Duhamel, A et al. High-dose tranexamic acid reduces blood loss in postpartum hemorrhage. Critical Care 2011; 15(2): R117.
19.WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389: 21052116.
20.Lavigne-Lissalde, G, Aya, AG, Mercier, FJ et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. Journal of Thrombosis and Haemostasis 2015; 13(4): 520529.
21.UK National Institute for Health and Clinical Excellence. Intraoperative Blood Cell Salvage in Obstetrics. IP Guidance Number: IPG144; 2005. http://www.nice.org.uk/guidance (accessed April 28 2015).
22.Allam, J, Cox, M, Yentis, SM. Cell salvage in obstetrics. International Journal of Obstetric Anesthesia 2008; 17: 3745.
23.Catling, S, Thomas, D. Intraoperative autologous blood transfusion. In Arulkumaran, S, Karoshi, M, Keith, LG, Lalonde, AB, B-Lynch, C (eds) A Comprehensive Textbook of Postpartum Hemorrhage, 2nd edn. Sapiens Publishing.
24.Teig, M, Harkness, M, Catling, S, Clark, V. Survey of cell salvage use in obstetrics in the UK. Poster presentation OAA meeting Sheffield June 2007. International Journal of Obstetric Anesthesia 2007; 16 (Suppl 1): 30.
25.Teare, KM, Sullivan, IJ, Ralph, CJ. Is cell salvaged vaginal blood loss suitable for re-infusion? International Journal of Obstetric Anesthesia 2015; 24(2): 103110.
26.Catling, SJ, Williams, S, Fielding, A. Cell salvage in obstetrics: an evaluation of ability of cell salvage combined with leucocyte depletion filter to remove amniotic fluid from operative blood loss at cesarean section. International Journal of Obstetric Anesthesia 1999; 8: 7984.
27.Hussain, S, Clyburn, P. Cell salvage-induced hypotension and London buses. Anesthesia 2010; 65(7): 661663.
28.UK Cell Salvage Action Group. Intraoperative Cell Salvage in Obstetrics. http://transfusionguidelines.org.uk/transfusion-practice/uk-cell-salvage-action-group/technical-factsheets-and-frequently-asked-questions-faq (accessed April 28 2015).
29.Sullivan, I, Faulds, J, Ralph, C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Cesarean section. British Journal of Anesthesia 2008; 101: 225229.
30.Davies, L, Brown, TJ, Haynes, S et al. Cost effectiveness of cell salvage and alternative methods of minimizing perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technology Assessment 2006; 10: 1228.
31.Khan, K, Moore, P, Wilson, MJ et al. LB01: Cell Salvage during Caesarean Section: A Randomised Controlled Trial (The SALVO Trial). American Journal of Obstetrics and Gynecology 2017; 216(1): S559 (Abstract).
32.The Maternal Critical Care Working Group. Providing Equity of Critical and Maternity Care for the Critically Ill Pregnant or Recently Pregnant Woman. https://www.rcoa.ac.uk/system/files/CSQ-ProvEqMatCritCare.pdf (accessed July 24 2017).